ALECMICRO

Alector, Inc.

HealthcareBiotechnology
$2.08
$0.00(+11.83%)
52W$1.09
$3.40
Updated Jun 30, 02:00 AM
RSI51
RS Rating31/99
Beta2.32
Volatility103%
F-Score1/9
Mkt Cap$231M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Alector, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 31), showing significant lag compared to the market leaders. Earnings growth of 49% provides fundamental context to the price action. Investors should exercise caution due to high volatility (103% annualized), which requires wider risk management.

Relative Strength
31
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
2.32
vs S&P 500
HIGH BETA
52W Position
43%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.08
50 SMA > 100 SMA$2.13
100 SMA > 150 SMA$1.94
150 SMA > 200 SMA$2.04

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.73+20.06%ABOVE
50 SMA$2.08+0.06%ABOVE
100 SMA$2.13-2.22%BELOW
150 SMA$1.94+7.21%ABOVE
200 SMA$2.04+1.74%ABOVE

Price Performance

1D+11.8%
1W+16.9%
1M-3.7%
3M+3.0%
6M+36.8%
YTD+35.9%
1Y+48.6%
3Y-29.2%
52-Week Trading Range43% from low
$2.08
52W Low$1.09
52W High$3.40

Technical Indicators

RSI (14)NEUTRAL
50.8
305070
Setup ScoreCOOL
1/10
Base depth: 63.9%

Risk Profile

Beta
2.32
52W Vol
103%
ATR
$0.14
Max DD (1Y)
-66%

Volume Analysis

Today
533.9K
50D Avg
675.1K
Vol Ratio
0.79x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+25%
$-0.30
Q3'25+23%
$-0.34
Q4'25-1511%
$-0.34
Q1'26+49%
$-0.21
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:-0.05%
3 Years:-46.00%
TTM:-79.15%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+6.38%

Stock Price CAGR

10 Years:-19.41%
5 Years:-36.79%
3 Years:-29.20%
1 Year:+48.57%

Return on Equity

10Y Avg:-101.6%
5Y Avg:-82.4%
3Y Avg:-115.9%
Last Year:-295.2%

Key Metrics

Market Cap$231M
Gross Margin54.1%
Net Margin-6.8%
Piotroski F-Score1/9

Frequently Asked Questions

Is ALEC in an uptrend right now?

ALEC has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is ALEC overbought or oversold?

ALEC's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.

Is ALEC outperforming the market?

ALEC has a Relative Strength (RS) Rating of 31 out of 99. ALEC is currently lagging the broader market.

Where is ALEC in its 52-week range?

ALEC is trading at $2.08, which is 61% of its 52-week high ($3.40) and 43% above its 52-week low ($1.09).

How volatile is ALEC?

ALEC has a Beta of 2.32 and 52-week volatility of 103%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.